iSpecimen (ISPC) Net Cash Flow Growth (1y) (2021 - 2026)
iSpecimen (ISPC) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 84.25% |
| 10 | iSpecimen | 692,995.30 | -2.13 Mn | 71,599.00 | -270.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -270.66% |
| Dec 31, 2025 | 3,138.20% |
| Sep 30, 2025 | 649.33% |
| Jun 30, 2025 | -413.33% |
| Mar 31, 2025 | -331.82% |
| Dec 31, 2024 | 133.49% |
| Sep 30, 2024 | -155.70% |
| Jun 30, 2024 | 103.49% |
| Mar 31, 2024 | 97.80% |
| Dec 31, 2023 | 92.94% |
| Sep 30, 2023 | 123.64% |
| Jun 30, 2023 | 26.99% |
| Mar 31, 2023 | -604.11% |
| Dec 31, 2022 | -129.80% |
| Sep 30, 2022 | 10.61% |
| Jun 30, 2022 | 28.56% |
| Mar 31, 2022 | -381.19% |
| Dec 31, 2021 | 6,967.86% |
| Sep 30, 2021 | -888.48% |